Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells

Citation
S. Saito et al., Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells, J HEART LUN, 18(10), 1999, pp. 937-945
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
JOURNAL OF HEART AND LUNG TRANSPLANTATION
ISSN journal
10532498 → ACNP
Volume
18
Issue
10
Year of publication
1999
Pages
937 - 945
Database
ISI
SICI code
1053-2498(199910)18:10<937:EOEONO>2.0.ZU;2-X
Abstract
Background: We find that chronic estradiol treatment inhibits the developme nt of transplant arteriosclerosis (TA). The mechanism of this inhibition re mains unclear. The objective of this study is to investigate in a non-cyclo sporin-requiring TA model whether estradiol-17 beta treatment modulates the expression of both endothelial nitric oxide synthase (ecNOS) and inducible nitric oxide synthase (iNOS) in the early phase following transplantation Methods: Orthotopic abdominal aorta allograft transplantation was performed in male rats using Brown-Norway rats as donors and Lewis rats as recipient s. The recipients (n = 50) were treated with estradiol 20 mu g/kg/day or pl acebo by osmotic minipump from 2 days prior to surgery until sacrifice on p ost-operative days 1, 3, 7, 14, and 21. The allografts were harvested and c ross-sections of the vascular tissues were used for immunohistochemical sta ining of ecNOS and iNOS. The effects of estradiol on cytokine-induced (tumo r necrosis factor-alpha and interleukin-l beta) iNOS protein and messenger RNA (mRNA) expression were also evaluated on rat aorta smooth muscle cells by Western blotting and RT-PCR in vitro, respectively. Results: The expression of ecNOS and iNOS was graded semiquantitatively fro m 0 to +3. Estrogen elevates ecNOS expression in the intima in the early ph ase following transplantation, 0.85 +/- 0.14 (day 7) and 1.08 +/- 0.11 (day 14) vs 1.53 +/- 0.25 (day 7) and 1.60 +/- 0.17 (day 14) for placebo and es tradiol treated groups respectively, p < 0.01. Estrogen suppresses iNOS exp ression in neointima (0.67 +/- 0.17 vs 0.24 +/- 0.04, p < 0.01, day 14), me dia (1.03 +/- 0.15 vs 0.4 +/- 0.09, p < 0.01, day 7), and adventitia (1.55 +/- 0.12 vs 1.02 +/- 0.10, p < 0.05, day 14) in the same phase. Estradiol t reatment inhibits cytokine-induced iNOS mRNA expression in cultured smooth muscle cells. Conclusions: Chronic estrogen treatment modulates both ecNOS and iNOS expre ssion in the early phase following transplantation. This is associated with the estrogen-protective effects on TA.